1. Home
  2. CRVL vs ARQT Comparison

CRVL vs ARQT Comparison

Compare CRVL & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorVel Corp.

CRVL

CorVel Corp.

HOLD

Current Price

$69.62

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$29.48

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVL
ARQT
Founded
1987
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.3B
IPO Year
1991
2020

Fundamental Metrics

Financial Performance
Metric
CRVL
ARQT
Price
$69.62
$29.48
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$24.83
AVG Volume (30 Days)
179.6K
1.8M
Earning Date
02-03-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
28.11
N/A
EPS
2.02
N/A
Revenue
$933,841,000.00
$317,929,000.00
Revenue This Year
N/A
$85.51
Revenue Next Year
N/A
$30.74
P/E Ratio
$33.74
N/A
Revenue Growth
10.43
129.21
52 Week Low
$65.47
$11.13
52 Week High
$128.61
$31.77

Technical Indicators

Market Signals
Indicator
CRVL
ARQT
Relative Strength Index (RSI) 49.36 52.91
Support Level $65.47 $27.71
Resistance Level $69.56 $30.26
Average True Range (ATR) 1.62 1.11
MACD 0.11 -0.13
Stochastic Oscillator 67.32 56.13

Price Performance

Historical Comparison
CRVL
ARQT

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: